1) erythrocyte sedimentation rate
血沉
1.
Nonlinear regression analysis between reference value of Chinese middlescent men s erythrocyte sedimentation rate(ESR) and geographical factors;
中年男性血沉参考值与中国地理因素的非线性回归分析
2.
Curvilinear model analysis between reference values of Chinese old women s erythrocyte sedimentation rate and altitude;
老年女性血沉正常参考值与海拔高度的曲线模型分析
2) ESR
血沉
1.
The study on the relationship between the blood concentration and ESR;
血液浓度与血沉关系的探讨
2.
The Clinical Value of C-reactive Protein,ESR and WBC Determination in Patients with Unstable Angina Pectoris;
不稳定型心绞痛患者血C-反应蛋白 血沉和白细胞联合测定的意义
3.
Multivariate Regression Analysis between the Reference Values ( Wintrobe ) of Chinese Healthy Adult and Old People s Erythrocyte Sedimentation Rate ( ESR ) and the Geographical Factors;
中国健康中老年人血沉参考值(温氏法)与地理因素的多元回归分析
3) Blood Sedimentation
血沉
1.
Methods Twenty patients enrolled were all met Yamaguchi criteria for claasification of adult's Still disease,their clinical features and treatment were reviewed,and the levels of serum ferritin,blood sedimentation,C reactive protein were detected.
方法分析20例成人Still病患者的临床特征和治疗措施,记录治疗前后用放免法测定的SF水平,并同时测定血沉(ESR)、C反应蛋白(CRP)水平,对SF与ESR、CRP进行相关性分析。
2.
The tolerance and safety of rhCTLA4-Ig were assessed based on blood and urine routine examination,blood sedimentation,electrocardiography,and blood biochemical tests.
方法随机选择健康志愿者27例,分别单次静脉滴注CTLA4-Ig 1、10、20 mg·kg~(-1),动态观测健康志愿者用药后的血、尿常规、血沉、心电图检查、胸片检查、血液生化检查等。
4) Erythrocyte sedimentation
血沉
1.
Erythrocyte sedimentation rates(ESR) were measured affter 10 minutes,20 minutes,30 minutes,and 60 minutes at room temperature using Westergren s method.
混匀后测各组红细胞压积,血红蛋白浓度和血气,于室温下用魏氏法测10 m in、20 m in、30 m in、60 m in血沉值,余血离心后取上清测血浆粘度和血浆胶体渗透压。
5) ESR measurement
血沉测定
6) ESR meter
血沉仪
1.
The technology evaluation of Erythrocyte Sedimentation Rate determining with Auto-ESR meter;
全自动快速血沉仪测定血沉的方法学评价
补充资料：血沉
血沉
又称红细胞沉降率，是表示红细胞悬浮稳定性大小的指标，通常是以红细胞在1小时内沉降的距离来表示红细胞下沉速度，常用魏氏法。正常小儿除新生儿(2mm以下）外各年龄组无显著差异，1～15mm/h；超过20mm/h，为异常。临床用于有感染、炎症与组织破坏等疾病的诊断与追踪观察；亦是肾脏疾病、结核感染、风湿病及其他结缔组织病的治疗中作为观察病情变化的一个指标。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条